Literature DB >> 22969780

Vitamin D and Parathyroid Hormone Relationships with Urinary Nitric Oxide Metabolites and Plasma Isoprostanes in African-Americans.

Anna Liza Valiña-Tóth1, Zongshan Lai, Shilling Zhang, John M Flack.   

Abstract

BACKGROUND: Vitamin D deficiency and secondary rises in parathyroid hormone (PTH) are highly prevalent in obese African-Americans. Endothelial dysfunction related to oxidative stress is more common in African-Americans compared to whites. Currently, the association of vitamin D (25-hydroxyvitamin D, 25-OH D) and PTH to nitric oxide metabolites (NOx) - nitrate and nitrite - and oxidative stress in African-Americans is unknown. Objective: A cross-sectional design was utilized to determine the association of 25-OH D and PTH with urinary NOx (UNOx) (n = 101) and plasma isoprostanes (n = 125), an oxidative stress marker, in overweight (body mass index of 25-39.9), normotensive African-Americans aged ≥35 years. Measurements: Multivariable linear regression analysis adjusted for age, sex, body mass index, and season was used to determine the relationship of 25-OH D and PTH to UNOx and isoprostanes. General linear models, adjusted for the same covariates, contrasted UNOx across three mutually exclusive vitamin D/PTH groups: (1) normal 25-OH D (51-249 nmol/l) and normal PTH (≤65 pg/ml); (2) low 25-OH D and normal PTH, and (3) low 25-OH D and high PTH.
RESULTS: 25-OH D was directly associated with UNOx before (p = 0.02) and after (p = 0.03) adjustment for PTH levels. A borderline significant association was observed between PTH and isoprostanes (p = 0.08). UNOx was 424, 290, and 270 μmol/8 h, respectively, across vitamin D/PTH groups 1-3 (p = 0.08).
CONCLUSION: 25-OH D was directly associated with NO availability and PTH was positively, though borderline, associated with isoprostanes in overweight, normotensive adult African-Americans.

Entities:  

Year:  2012        PMID: 22969780      PMCID: PMC3433000          DOI: 10.1159/000339942

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  27 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  1Alpha,25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production.

Authors:  Xiaocun Sun; Michael B Zemel
Journal:  Obesity (Silver Spring)       Date:  2007-08       Impact factor: 5.002

3.  NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa.

Authors:  Yiling Fu; Rui Zhang; Deyin Lu; Haifeng Liu; Kiran Chandrashekar; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-06       Impact factor: 3.619

4.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

5.  Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study.

Authors:  R B D'Agostino; G Burke; D O'Leary; M Rewers; J Selby; P J Savage; M F Saad; R N Bergman; G Howard; L Wagenknecht; S M Haffner
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

6.  Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans.

Authors:  Anna Liza B Valiña-Tóth; Zongshan Lai; Wonsuk Yoo; Abdul Abou-Samra; Crystal A Gadegbeku; John M Flack
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-28       Impact factor: 3.478

7.  Plasma adiponectin concentrations and correlates in African Americans in the Hypertension Genetic Epidemiology Network (HyperGEN) study.

Authors:  James M Shikany; Cora E Lewis; Barry I Freedman; Donna K Arnett; Catherine Leiendecker-Foster; Tamekia L Jones; David T Redden; Albert Oberman
Journal:  Metabolism       Date:  2007-08       Impact factor: 8.694

8.  Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.

Authors:  Leszek Kalinowski; Iwona T Dobrucki; Tadeusz Malinski
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

9.  1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

Authors:  Weihua Yuan; Wei Pan; Juan Kong; Wei Zheng; Frances L Szeto; Kari E Wong; Ronald Cohen; Anna Klopot; Zhongyi Zhang; Yan Chun Li
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

10.  Epidemiology of hypertension and hypertensive target-organ damage in the United States.

Authors:  J M Flack; W H Wiist
Journal:  J Assoc Acad Minor Phys       Date:  1991
View more
  4 in total

1.  Heart valve disease: the role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency.

Authors:  Esin Eren; Hamit Yasar Ellidag; Yesim Cekin; Raif Umut Ayoglu; Ali Osman Sekercioglu; Necat Yılmaz
Journal:  Redox Rep       Date:  2013-11-26       Impact factor: 4.412

Review 2.  Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy.

Authors:  Bipradas Roy; Mary E Curtis; Letimicia S Fears; Samuel N Nahashon; Hugh M Fentress
Journal:  Front Physiol       Date:  2016-09-29       Impact factor: 4.566

3.  Associations of Serum Nitric Oxide with Vitamin D and Other Metabolic Factors in Apparently Healthy Adolescents.

Authors:  Nasser M Al-Daghri; Ihtisham Bukhari; Sobhy M Yakout; Shaun Sabico; Malak N K Khattak; Ibrahim Aziz; Majed S Alokail
Journal:  Biomed Res Int       Date:  2018-08-05       Impact factor: 3.411

4.  Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D.

Authors:  Keith C Norris; M Edwina Barnett; Yuan-Xiang Meng; David Martins; Susanne B Nicholas; Gary H Gibbons; Jae Eun Lee
Journal:  Contemp Clin Trials       Date:  2018-07-18       Impact factor: 2.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.